Evangelos D. Karousis
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 3
- SARS-CoV-2 and COVID-19 Research 3
-
- RNA and protein synthesis mechanisms 8
- RNA Research and Splicing 8
- RNA modifications and cancer 5
- CRISPR and Genetic Engineering 2
- RNA regulation and disease 1
- Animal Science and Zoology top 10%
-
- Viral Infections and Immunology Research 4
- Co-authors
- Oliver MühlemannSofía NasifLukas‐Adrian GurzelerKatharina SchubertNenad BanMarc LeibundgutAlain ScaiolaVolker Thiel
- Journals
- Nature Structural & Molecular Biology (2 papers)The EMBO Journal (1 paper)Wiley Interdisciplinary Reviews - RNA (1 paper)
- Partner nations
- SwitzerlandRussiaUnited States
In The Last Decade
Evangelos D. Karousis
13 papers receiving 954 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Infectious Diseases 321
- Molecular Biology 677
- Immunology 114
- Animal Science and Zoology 54
- Cardiology and Cardiovascular Medicine 111
Countries citing papers authored by Evangelos D. Karousis
This map shows the geographic impact of Evangelos D. Karousis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos D. Karousis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos D. Karousis more than expected).
Fields of papers citing papers by Evangelos D. Karousis
This network shows the impact of papers produced by Evangelos D. Karousis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos D. Karousis. The network helps show where Evangelos D. Karousis may publish in the future.
Co-authorship network
The 18 scholars most cited alongside Evangelos D. Karousis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 24 | |
| 6 | 2022 | 34 | |
| 7 | 2021 | 37 | |
| 8 | SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translationbreakdown → | 2020 | 383 |
| 9 | 2020 | 15 | |
| 10 | 2020 | 30 | |
| 11 | 2018 | 143 | |
| 12 | 2016 | 135 | |
| 13 | 2016 | 146 | |
| 14 | 2014 | 3 |
About Evangelos D. Karousis
Evangelos D. Karousis is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Molecular Biology, Cell Biology and Oncology, having authored 14 papers that have together received 962 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (8 papers), RNA Research and Splicing (8 papers), RNA modifications and cancer (5 papers), Viral Infections and Immunology Research (4 papers), Viral gastroenteritis research and epidemiology (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), CRISPR and Genetic Engineering (2 papers) and RNA regulation and disease (1 paper). The work is most often cited by research in Infectious Diseases (321 citations), Molecular Biology (677 citations), Immunology (114 citations), Animal Science and Zoology (54 citations) and Cardiology and Cardiovascular Medicine (111 citations). Evangelos D. Karousis has collaborated with scholars based in Switzerland, Russia and United States. Frequent co-authors include Oliver Mühlemann, Sofía Nasif, Lukas‐Adrian Gurzeler, Katharina Schubert, Nenad Ban, Marc Leibundgut, Alain Scaiola, Volker Thiel, Ahmad Jomaa and Rémy Bruggmann. Their work appears in journals such as Nature Structural & Molecular Biology, The EMBO Journal, Wiley Interdisciplinary Reviews - RNA, Journal of Biological Chemistry and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.